Advances in Sjögren's Syndrome Dry Eye Diagnostics: Biomarkers and Biomolecules beyond Clinical Symptoms

Biomolecules. 2024 Jan 8;14(1):80. doi: 10.3390/biom14010080.

Abstract

Sjögren's syndrome dry eye (SSDE) is a subset of Sjögren's syndrome marked by dry eye symptoms that is distinct from non-Sjögren's syndrome dry eye (NSSDE). As SSDE can lead to severe complications, its early detection is imperative. However, the differentiation between SSDE and NSSDE remains challenging due to overlapping clinical manifestations. This review endeavors to give a concise overview of the classification, pathophysiology, clinical features and presentation, ocular and systemic complications, clinical diagnosis, and management of SSDE. Despite advancements, limitations in current diagnostic methods underscore the need for novel diagnostic modalities. Thus, the current review examines various diagnostic biomarkers utilized for SSDE identification, encompassing serum, salivary, and tear analyses. Recent advancements in proteomic research and exosomal biomarkers offer promising diagnostic potential. Through a comprehensive literature review spanning from 2016 to 2023, we highlight molecular insights and advanced diagnostic modalities that have the potential to enhance our understanding and diagnosis of SSDE.

Keywords: Sjögren’s syndrome dry eye; diagnostic biomarkers; exosomal biomarkers; molecular diagnostics; ocular surface disease; ophthalmology; salivary analysis; serum analysis; tear analysis; tear proteomics.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Dry Eye Syndromes* / diagnosis
  • Eye
  • Humans
  • Proteomics
  • Sjogren's Syndrome* / diagnosis

Substances

  • Biomarkers

Grants and funding

This research received no external funding.